liver to excrete copper into the bile. As with many human recessive genetic disorders, there are a very large number, over 100 so far, of identified mutations which either knock out or seriously cripple the Wilson's disease gene, and result in the clinical disease [8] .
From the genetic perspective, Wilson's disease is viewed as a recessive disorder. By this it is meant, of course, that it takes two copies of the defective gene, either in homozygous form or compound heterozygous form, to produce the disease. However, over the years that we have been working on Wilson's disease and diagnosing affected patients and differentiating them from heterozygous carriers, it has become clear to us that the Wilson's disease gene is not completely recessive [1, [9] [10] [11] . In the first place, whereas 80-90% of affected patients have very low to modestly reduced serum ceruloplasmin (Cp) levels, 10-20% of carriers also have modestly low levels of serum Cp [1, 2] . In keeping with the reduced serum Cp levels, heterozygotes also have an abnormal rate of incorporation of radio-copper into Cp for release into the blood. In this procedure, developed by others [12] , radio-labeled copper is administered either intravenously or orally at time zero. At 1-2 hr following oral administration (and sooner of course with IV administration), there is a blood peak of radioactivity. After that the level of blood radioactivity decreases sharply and then, over the next 24 hr, slowly builds up again as radio-copper is incorporated into Cp in the liver and the Cp is released into the blood. Thus, there is a second radioactive peak at 24 hr. In Wilson's disease patients, as is clearly shown in Figure 1 taken from our work [1] , there is a markedly reduced rate of release of radio-labeled Cp into the blood compared to normals. The main point to be made here is that heterozygous carriers have an intermediate overall rate of appearance of radio-copper, and in some cases the abnormality is as extreme as it is in affected patients (Fig. 1) .
Heterozygous carriers also accumulate copper abnormally in their livers (Fig. 2) . In working up siblings of affected patients in order to differentiate affected patients from carriers, we have often had to do liver biopsies for final diagnosis. Two-thirds of the siblings who do not have Wilson's disease will be heterozygous carriers on probablistic grounds. We find an elevated hepatic copper in the majority of siblings who are likely heterozygotes (Fig. 2, lower panel) . Figure 2 (upper panel) also shows data on a number of nonsibling patients we worked up for Wilson's disease and excluded the diagnosis. Chances are good that many of these subjects are heterozygous carriers, and many have abnormally elevated hepatic copper levels.
We have much more extensive data on urine copper values in siblings of affected patients. Again, after we exclude the diagnosis of Wilson's disease, two-thirds of the remaining siblings will be heterozygotes, based on probabilities. As can be seen from Figure 3 , urine copper levels are elevated abnormally in a little over half of the calculated number of heterozygous siblings.
Thus, summarizing the data in heterozygous carriers of the Wilson's disease gene defect, we find that the gene really is codominant in many respects, with intermediate abnormalities of ceruloplasmin release into the blood and copper accumulation abnormalities in liver and urine. These data suggest that under environmental circumstances of increased copper ingestion, Wilson's disease could be made into a dominant disorder, that is, copper toxicity could be seen in heterozygous carriers.
In examining the data from some of the infantile and childhood cirrhosis syndromes associated with high levels of copper in the liver, it has occurred to me that those infants and small children may have exhibited precisely what is hypothesized above, i.e., that the affected children are heterozygous carriers of the Wilson's disease gene defect. To review these syndromes briefly, between 1900 and 1980, 138 infants and young children died in the Tyrolean area of Western Austria from liver cirrhosis associated with very high levels of hepatic copper [13] . Since about 1980, this syndrome has essentially disappeared. A common feature of this disorder was the feeding of infants and young children with a preparation called "feeding milk," which is a 1:1 mixture of unpasturized cow's milk with water. This material was heated for about 20 min in copper or brass pots. When this process was repeated later, investigators found that a very high level of copper from the pots appeared in the feeding milk [13] . Traditional copper cooking utensils were gradually replaced with modern industrial vessels, and this disease gradually disappeared by about 1980.
Assuming that the frequency of carriers of the Wilson's disease gene defect is about 1% in the Tyrolean area as it is currently estimated to be in most populations, the data on the number of infants affected with Tyrolean infantile cirrhosis are quite compatible with the hypothesis that the affected children were carriers of the Wilson's disease gene. The population size involved was about 45,000 [13] . At its peak, the epidemic had about 3.8 affected infant cases per year [13] . That number of Wilson's disease carriers would easily have been generated from a population of this size. The Tyrolean disease appeared to be genetically determined, as it occurred in some families but not in others in the same environment and presumably using the same feeding milk preparation, and was recessive, as in many families multiple siblings were involved [13] .
Indian childhood cirrhosis is remarkable similar to Tyrolean infantile cirrhosis [14] [15] [16] [17] [18] [19] . It occurs in India in infants or very young children fed milk stored in brass or copper containers. The milk has been shown to have a very high copper content, and the disease is familial, with a recessive segregation pattern. Again, the cirrhosis appears to be due to copper toxicity in the liver. The role of copper in this case is supported not only by the high copper concentrations in the liver but also by rapid improvement with penicillamine treatment.
The third syndrome is referred to as idiopathic copper toxicosis [20] . This syndrome has occurred in many countries, and often other names are used, such as copper-associated childhood cirrhosis, Indian childhood cirrhosis-like, and copperassociated liver disease in childhood. In a review by Muller et al. [20] , 15 previous reports were analyzed. Many of the cases appeared in infants or very young children, but some occurred in children up to 10 years of age. A feature in common was cirrhosis associated with very high levels of hepatic copper. In many, but not in all cases, increased ingestion of copper had been shown. There was often involvement of more than one sibling. The majority of the cases of ICT appear associated with elevated copper in drinking water. For example, in the review of Muller et al. [20] , there were 15 papers reporting ICT. In eight of these, copper in tap water was reported, and in five of the eight (involving eight patients), copper levels were elevated in drinking water. In the other three reports (involving six patients), presumably the copper came from some source other than the drinking water. Involvement of a genetic (or at least a familial) component was suggested in some cases by involvement of multiple siblings.
In summary then, the infantile and childhood cirrhosis syndromes associated with elevated levels of hepatic copper all have in common that they occur in infants and young children, that an increased intake of copper can usually be identified, that copper toxicity appears to be occurring in the liver causing cirrhosis, and that there are indications of a genetic contribution segregating in a recessive manner.
Given that we have shown that heterozygous carriers of the Wilson's disease gene are susceptible to copper accumulation, even in an environment of presumed normal copper intake, it is a reasonable hypothesis that these infantile and childhood copper toxicosis/cirrhosis syndromes are often, if not always, a result of disease in heterozygous carriers of the Wilson's disease gene defect. Under these circumstances, the disease would have been converted to a dominant by the environmental situation of a high copper intake. Unlike most dominant genetic defects, the disease is not seen in a parent because the heterozygous parent is not exposed to the same environment as the heterozygous infant, that is, the environment of a high copper intake. The infants and young children are either drinking milk with high copper or taking formula made with copper-contaminated drinking water.
Can this hypothesis be tested? To the extent that parents of children who were affected with this syndrome are still available, either in India or Tyrol, or in some of the ICT cases, one of the two parents in these families should be heterozygous for a Wilson's disease gene defect. It seems to me that perhaps the easiest way to test the hypothesis would be to set up a DNA test for the most common one or two mutations producing Wilson's disease, and to study these parents to determine the frequency of those mutations. For example, if mutations which normally comprise about 50% of Wilson's disease mutations in a given population are tested for, it would be expected that one out of every two families would have a parent with one of these mutations, if a large proportion of the cases involve Wilson's disease heterozygosity.
